An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (17 July 2019).
NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.
Shared Learning Award 2019 finalist
NICE has today (28 August 2019) published its updated guideline on the diagnosis and treatment of high blood pressure (hypertension).
More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
Approving regorafenib is a "welcome step forward" for those people who are eligible
Sarah Fishburn, quality improvement for Thames Valley Strategic Clinical Network, discusses how postnatal mental health care can be improved
NICE has issued new advice to help doctors quickly spot Lyme disease, so they can offer people NHS treatment as soon as possible.
NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.
NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.
NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.
NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast cancer does not prove it prolongs survival more than existing, less expensive treatments.
NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.
NICE is calling for people who are eligible for free flu vaccination to be offered it at every opportunity.
Deborah tells us how the judging panel have whittled the NICE shared learning award entries down from 64 to a shortlist of 20.
NICE is calling on general practice staff to assess the mental health of all women who have recently given birth, as fears some may be left unsupported.
NICE has recommended the Intrabeam Radiotherapy System for people with early breast cancer in limited circumstances with additional data collection.
People who drink too much should be sent for scans to detect early liver disease, says NICE
People at risk of fractures due to osteoporosis should be considered for medication, Nice says.
NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink tumours in some people with breast cancer so surgery can take place.
People with advanced breast cancer are set to benefit from a life-extending drug as NICE says it should be available on the NHS.
NICE is calling for women to be told that the coil is more effective than the ‘morning after pill’ for emergency contraception, in a new quality standard.
New draft guidance from NICE means thousands of people with back condition ankylosing spondylitis will soon have access to an innovative new drug.
NICE draft guidance recommends non-invasive prenatal testing (NIPT) for fetal rhesus-D status.
NICE has launched a suite of guidelines to ensure that trauma services are delivered effectively and consistently.
NICE has welcomed proposed new guidelines on alcohol which aim to limit the health risks that result from drinking.
NICE has appointed Dr Rosie Benneyworth, a GP and former commissioner, as a new Non-Executive Director (NED) to its Board.
A short summary of guidance and advice that generated the most interest during the second half of 2015.
Here’s a short summary of the guidance and advice that has generated the most interest during the first half of 2015.
Women whose lives are being affected by the symptoms menopause should not feel they have to suffer in silence, says NICE.
People should be encouraged to stop smoking, be more physically active, reduce their alcohol consumption, and adopt a healthy diet to help lower the risk of developing dementia, disability and frailty in later life.
lifestyle and personal or family medical history. We recommend that menopausal women discuss with their doctors their own individual...
NICE’s latest quality standard on osteoarthritis includes eight statements designed to tackle variation in the care of people with osteoarthritis.
Ensuring people develop healthy habits from an early age can help prevent long-term disease and early death, says NICE.
GPs and other health and social care professionals have a huge untapped opportunity to spot and help vulnerable people whose health is at risk because of living in a cold home, says NICE.
Improving the uptake of hepatitis B vaccination among at risk groups, developing tools to make evidence-based medicine more accessible, and carrying out a clinical outcome assessment in hand surgery are just some of the projects planned by the latest group of fellows and scholars.
Women in established labour should receive supportive one-to-one care to ensure they have a safe experience of giving birth, NICE says.
NICE’s first guideline on bladder cancer aims to improve the diagnosis and management of the seventh most common cancer in the UK.
Why are so many of us getting cancer and what can be done to prevent the disease?
NICE’s latest quality standard can help GPs and other healthcare professionals ensure that women with urinary incontinence are receiving the best and most appropriate care.
A quick look at the guidance and advice that generated the most interest from July to December.
Women who have experience of, or are at risk of mental health problems, should get extra support before, during and after their pregnancy, says NICE.
The Academy of Medical Royal Colleges recently described our 'do not do' database as an excellent resource. The database allows you to search for recommendations that we've made on a clinical practice that should either be discontinued or not used routinely within the NHS. Take a look at the top 5 recommendations:
Chair of NICE Professor David Haslam reflects on the worldwide effects of mental health, and the importance of treating depression as any other disease.